戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 erstitial cells of Cajal (ICCs) is common in diabetic gastroparesis.
2 is and compare findings in idiopathic versus diabetic gastroparesis.
3 strointestinal motility disorders, including diabetic gastroparesis.
4 ht be a therapeutic option for patients with diabetic gastroparesis.
5 ing studies on the morbidity associated with diabetic gastroparesis.
6 changes in the gastric wall in patients with diabetic gastroparesis.
7  in patients with diabetes) in patients with diabetic gastroparesis.
8  a loss of Kit expression and development of diabetic gastroparesis.
9 has shown to be beneficial in idiopathic and diabetic gastroparesis.
10 cells could contribute to the development of diabetic gastroparesis.
11 expression in ICC may directly contribute to diabetic gastroparesis.
12 cterized clinical profiles in idiopathic and diabetic gastroparesis and are defining roles of gastric
13          We identified a correlation between diabetic gastroparesis and cardiovascular disease, hyper
14 no1 gene in gastric muscles of patients with diabetic gastroparesis and nondiabetic control tissues.
15 vomiting and also improved other symptoms of diabetic gastroparesis compared with placebo.
16                                              Diabetic gastroparesis (delayed gastric emptying) is a w
17  proposed that Kit expression is lost during diabetic gastroparesis due to increased levels of oxidat
18                   Furthermore, patients with diabetic gastroparesis express mRNA for a previously unk
19                                              Diabetic gastroparesis involves neuropathy, myopathy, an
20        The importance of glycemic control in diabetic gastroparesis is a focus of current investigati
21 e) intended to reduce the aspiration risk of diabetic gastroparesis is likely over-utilized and may o
22              The pathophysiological basis of diabetic gastroparesis is poorly understood, in large pa
23         In a clinical trial of patients with diabetic gastroparesis, relamorelin (10 mug twice daily)
24 ession and splicing of Ano1 in patients with diabetic gastroparesis that alter the electrophysiologic
25 an age, 55 y; 88% with type 2 diabetes) with diabetic gastroparesis with moderate to severe symptoms

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。